LivaNova (LIVN) revenue

Revenue · fiscal 2025
$1.39B

LivaNova (LIVN) reported revenue of $1.39B in fiscal 2025 (the year ended December 31, 2025). That is 10.7% higher than the $1.25B of fiscal 2024. Figures as of 18 Nov 2026, 09:58 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$1.39B
Change on fiscal 2024
+10.7%
Growth, 5 years
+8.2% a year
Growth, 10 years
+16.9% a year
Highest on record
$1.39Bfiscal 2025
Lowest on record
$254.32Mfiscal 2013
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

LivaNova revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 8.2% a year; over ten years the rate was 16.9% a year. Across the 13 fiscal years on record (2013–2025), the highest was $1.39B in fiscal 2025 and the lowest $254.32M in fiscal 2013.

History · 13 fiscal years

Revenue by fiscal year

LivaNova revenue, year by year

LivaNova (LIVN) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$1.39B 10.7% up
2024$1.25B 8.7% up
2023$1.15B 12.9% up
2022$1.02B 1.3% down
2021$1.04B 10.8% up
2020$934.24M 13.8% down
2019$1.08B 2.1% down
2018$1.11B 9.4% up
2017$1.01B 4.9% up
2016$964.86M 230.9% up
2015$291.56M 3.4% up
2014$282.01M 10.9% up
2013$254.32M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of LivaNova and comparable companies
CompanyRevenueFiscal year
LivaNova LIVN$1.39B2025
Ionis Pharmaceuticals IONS$943.71M2025
Dianthus Therapeutics DNTH$2.04M2025
MiniMed Group MMED$3.10B2026
Adaptive Biotechnologies ADPT$276.98M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LIVN

LivaNova, figure by figure

LivaNova (LIVN) overview: price, valuation and scorecardAll health care companies by market value

LivaNova revenue: questions and answers

What is LivaNova's revenue?

LivaNova (LIVN) reported revenue of $1.39B in fiscal 2025 (the year ended December 31, 2025). That is 10.7% higher than the $1.25B of fiscal 2024.

What is the growth rate of LivaNova's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 8.2% a year; over ten years the rate was 16.9% a year.

What are the highest and lowest revenue figures on record for LivaNova?

Across the 13 fiscal years on record (2013–2025), the highest was $1.39B in fiscal 2025 and the lowest $254.32M in fiscal 2013.

How is LivaNova's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For LivaNova it is on record here for 13 fiscal years, 2013 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “LivaNova (LIVN) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/LIVN/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.